Overview
Daniel Zambon practices in Barcelona, Spain. Mr. Zambon is rated as a Distinguished expert by MediFind in the treatment of Heterozygous Familial Hypercholesterolemia (HeFH). His top areas of expertise are Familial Hypercholesterolemia, High Cholesterol, Heterozygous Familial Hypercholesterolemia (HeFH), and Defective Apolipoprotein B-100.
His clinical research consists of co-authoring 22 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 11 articles in the study of Heterozygous Familial Hypercholesterolemia (HeFH).
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Defective Apolipoprotein B-100Mr. Zambon isDistinguished. Learn about Defective Apolipoprotein B-100.
- Familial HypercholesterolemiaMr. Zambon isDistinguished. Learn about Familial Hypercholesterolemia.
- Heterozygous Familial Hypercholesterolemia (HeFH)
- High CholesterolMr. Zambon isDistinguished. Learn about High Cholesterol.
- Experienced
- AtherosclerosisMr. Zambon isExperienced. Learn about Atherosclerosis.
- CalcinosisMr. Zambon isExperienced. Learn about Calcinosis.
- Coronary Heart DiseaseMr. Zambon isExperienced. Learn about Coronary Heart Disease.
- Familial HypertriglyceridemiaMr. Zambon isExperienced. Learn about Familial Hypertriglyceridemia.
- Homozygous Familial Hypercholesterolemia (HoFH)